Aldesleukin biosimilar (Amega Biotech)

Aldesleukin生物类似药（Amega Biotech）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAldesleukin biosimilar (Amega Biotech)

Drug Alias NameRecombinant interleukin 2 biosimilar - Amega BiotechAldesleukin生物仿制药（Amega Biotech）Recombinant interleukin-2 - Amega BiotechIL-2 - Amega Biotech

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists

TargetsInterleukin-2 receptor

Therapy Area/IndicationsCarcinoma, Renal CellMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsCarcinoma, Renal CellMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeL03AC01